Robert S. Turner
Deep brain stimulation and neuromodulation therapies for movement disorders (Parkinson's disease and dystonia). Neurophysiologic studies of DBS mechanisms in non-human primates.
Research in my lab uses non-human primate models to address three primary questions:
1) What does the basal ganglia contribute to the control of movement and executive function in healthy individuals?
2) What pathophysiologic processes underlie the signs of basal ganglia-related disorders such as Parkinson's disease and dystonia?
3) How does deep brain stimulation (DBS) work to alleviate symptoms in Parkinson's disease, essential tremor, dystonia, OCD/Tourette's, and an expanding array of other potential applications?
1) What does the basal ganglia contribute to the control of movement and executive function in healthy individuals?
2) What pathophysiologic processes underlie the signs of basal ganglia-related disorders such as Parkinson's disease and dystonia?
3) How does deep brain stimulation (DBS) work to alleviate symptoms in Parkinson's disease, essential tremor, dystonia, OCD/Tourette's, and an expanding array of other potential applications?